Eli Lilly and Company (LLY) stock news · P/E 43, rev $65.18B
Eli Lilly and Company (LLY) is a drug manufacturers - general company listed on NYSE. It is led by David A. Ricks.
This LLY news page leads with what Eli Lilly and Company filed — not a scraped headline mill.
No cached 8-K sentence for LLY yet. We will not pad this page with generic market recap.
Latest reported LLY revenue for 2025-12-31 was $65.18B. Net income was $20.64B. Revenue was up 44.7% from 2024-12-31 to 2025-12-31. LLY currently screens at market cap $991.62B and trailing P/E 42.7.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the LLY stock page; for the tape open the quote page.
LLY stock news FAQ
What are LLY's latest revenue and net income?
Latest cached Eli Lilly and Company (LLY) revenue for Dec 31, 2025 was $65.18B. Net income was $20.64B. Statements: https://lician.com/financials/lly
How did LLY revenue change from the prior cached period?
Cached Eli Lilly and Company (LLY) revenue was up 44.7% from $45.04B (Dec 31, 2024) to $65.18B (Dec 31, 2025). Statements: https://lician.com/financials/lly
What is LLY's P/E ratio?
Eli Lilly and Company (LLY) trailing P/E is 42.7 on the latest cached fundamentals snapshot.
What is LLY's market cap?
Eli Lilly and Company (LLY) market cap is $991.62B on the latest cached fundamentals snapshot.
What kind of company is LLY?
Eli Lilly and Company (LLY) is a drug manufacturers - general company listed on NYSE.
Where is LLY stock news listed?
Cached stock news for Eli Lilly and Company (LLY) is listed at https://lician.com/news/lly. Filings: https://lician.com/sec/lly
Not investment advice.